Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02739243
Other study ID # S-655/2015
Secondary ID ISRCTN22231701
Status Withdrawn
Phase Phase 3
First received April 7, 2016
Last updated October 24, 2016
Start date April 2016
Est. completion date October 2016

Study information

Verified date October 2016
Source Heidelberg University
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

Background and study aims: Being a caregiver for someone with cancer can be very difficult emotionally. For many the patient is a family member or friend, and so this can cause the caregiver a great deal of psychological distress. There are currently very few studies looking into the effectiveness of psychological treatments for distressed caregivers of cancer patients. This study is looking at tailored group therapy program for carers of cancer givers. The aim of this study is to find out whether this program can help to lower levels of distress in cancer caregivers and help them to better cope with caring for someone with the illness.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 2016
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Time since initial diagnosis (of patient) not longer than six months previously

2. Significant distress against the background of the cancer disease (QSC-R10C exceeding 16 points)

3. Provision of informed consent

4. Aged 18 or over, either gender

Exclusion Criteria:

1. Inability to give informed consent

2. Insufficient German language knowledge

3. Cognitive impairment impeding handling of questionnaires

4. Severe psychiatric disease (acute psychosis or acute suicidality)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Distress in Caregivers of Cancer Patients

Intervention

Behavioral:
Tailored group intervention (PREPARE)

Individual treatment as usual


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Heidelberg University

Outcome

Type Measure Description Time frame Safety issue
Primary Distress measured using the Questionnaire on Stress in Caregivers of Cancer Patients Revised version (QSC-R10C) change from baseline distress at 1 week post treatment No
Secondary Depression measured using the Patient Health Questionnaire-9 (PHQ-9) change from baseline depression at 1 week post treatment and at 6 months post treatment No
Secondary Anxiety measured using the Generalized Anxiety Disorder-7 (GAD-7) change from baseline anxiety at 1 week post treatment and at 6 months post treatment No
Secondary General distress measured using the Distress Thermometer (NCCN DT) change from baseline general distress at 1 week post treatment and at 6 months post treatment No
Secondary Unmet needs measured using the Supportive Care Needs Survey - Partners & Caregivers (SCNS-P&C-G) change from baseline unmet needs at 1 week post treatment and at 6 months post treatment No
Secondary Self-efficacy in coping with the cancer disease measured using the adapted General Perceived Self-Efficacy Scale change from baseline self-efficacy at 1 week post treatment and at 6 months post treatment No
Secondary Utilisation of primary healthcare measured via the number of visits with the individual primary care physician change from baseline to 1 week post treatment and 6 months post treatment No
Secondary Positive bonding with the group measured via the Positive Bonding Scale of the Group Questionnaire (GQ-D) change from baseline bonding at 1 week post treatment and 6 months post treatment No